Evidence map›Paper›PMID 21256127›Full record

ArticleExperimental cell research2011

The cation channel mucolipin-1 is a bifunctional protein that facilitates membrane remodeling via its serine lipase domain.

Janice M LaPlante, John L Falardeau, Edward M Brown, Susan A Slaugenhaupt, Peter M Vassilev

Open access · greenAbstract read
In one paragraph

Article in Experimental cell research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Lysosomal TRPML1 Channel: Implications in Cardiovascular and Kidney Diseases.Advances in experimental medicine and biology · 2021
    Article
  2. Inherited disorders of lysosomal membrane transporters.Biochimica et biophysica acta. Biomembranes · 2020
    Review
  3. Article
  4. Review
  5. Structural biology of TRP channels.Handbook of experimental pharmacology · 2014
    Review
  6. Article
  7. Article
  8. Review
  9. Mucolipidosis type IV: an update.Molecular genetics and metabolism · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Janice M LaPlanteDivision of Endocrinology, Diabetes and Hypertension and Membrane Biology Program, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. jlaplante@rics.bwh.harvard.edu
John L Falardeau
Edward M Brown
Susan A Slaugenhaupt
Peter M Vassilev
Brigham and Women's Hospital · USHarvard University · USMassachusetts General Hospital · US

Funding

MOLECULAR ANALYSIS OF MUCOLIPIDOSIS IVR01NS039995 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI SLAUGENHAUPT, SUSAN A · 2000 to 2010
$4.2M
Elucidation and rescue of phenotypic alterations in MLIVR01HD046667 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · PI VASSILEV, PETER M · 2005 to 2009
$1.9M
Effects of dietary agents on lysosomes in mucolipidosisR21AT001935 · NCCIH · BRIGHAM AND WOMEN'S HOSPITAL · PI VASSILEV, PETER M · 2004 to 2005
$425k
NCCIH NIH HHS R21 AT001935NICHD NIH HHS R01 HD046667NINDS NIH HHS NS39995NINDS NIH HHS R01 NS039995
6 · The paper itself

Abstract

Phospholipase modulators have been shown to affect the topology of lipid bilayers and the formation of tubulo-vesicular structures, but the specific endogenous phospholipases involved have yet to be identified. Here we show that TRPML1 (MLN1), a Ca(2+)-permeable channel, contributes to membrane remodeling through a serine lipase consensus domain, and thus represents a novel type of bifunctional protein. Remarkably, this serine lipase active site determines the ability of MLN1 to generate tubulo-vesicular extensions in mucolipin-1-expressing oocytes, human fibroblasts and model membrane vesicles. Our demonstration that MLN1 is involved in membrane remodeling and the formation of extensions suggests that it may play a role in the formation of cellular processes linked to the late endosome/lysosome (LE/L) pathway. MLN1 is absent or mutated in patients with mucolipidosis IV (MLIV), a lysosomal disorder with devastating neurological and other consequences. This study provides potential insight into the pathophysiology of MLIV.

Indexed as

AnimalsCell MembraneFibroblastsHumansLipaseMembrane Fusion ProteinsMucolipidosesMutationProtein Structure, TertiaryTransient Receptor Potential ChannelsTRPM Cation ChannelsXenopus laevisLipaseMCOLN1 protein, humanMembrane Fusion ProteinsTransient Receptor Potential ChannelsTRPM Cation Channels

Identifiers

PMID21256127
PMCPMC3103141
OpenAlexW2078670819

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.